CliffBio
small molecule

CYCLOBENZAPRINE HYDROCHLORIDE

CYCLOBENZAPRINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTWI PHARMACEUTICALS INC

Drug detail

Brand nameCYCLOBENZAPRINE HYDROCHLORIDE
Active ingredientCYCLOBENZAPRINE HYDROCHLORIDE
Strength15MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2013
Marketing statusRX

More from TWI PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.